Author:
Scott David A.,Bell Kirsten J.,Campbell Cheryl T.,Cook Donald J.,Dakin Les A.,Del Valle David J.,Drew Lisa,Gero Thomas W.,Hattersley Maureen M.,Omer Charles A.,Tyurin Boris,Zheng Xiaolan
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference9 articles.
1. Scott, D. A.; Balliet, C. L.; Cook, D. J.; Davies, A. M.; Gero, T. W.; Omer, C. A.; Poondru, S.; Theoclitou, M.-E.; Tyurin, B.; Zinda, M. J. Bioorg. Med. Chem. Lett. 2008, preceding paper.
2. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug
3. Studies leading to the identification of ZD1839 (iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer
4. Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancer
5. Rational Development of Practical Catalysts for Aromatic Carbon−Nitrogen Bond Formation
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献